Cargando…

Identification and Validation of Hypoxia-Related lncRNA Signature as a Prognostic Model for Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the most general malignant tumors. Hypoxia is a critical clinical characteristic and acts as a significant part in the development and cancers’ prognosis. The prognostic value and biological functions of hypoxia-related lncRNAs in hepatocellular carcinoma is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Chenghui, Zhang, Huajun, Lu, Liqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505699/ https://www.ncbi.nlm.nih.gov/pubmed/34650600 http://dx.doi.org/10.3389/fgene.2021.744113

Ejemplares similares

Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer
por: Li, Danfeng, et al.
Publicado: (2021)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Identification and Validation of Necroptosis-Related LncRNA Signature in Hepatocellular Carcinoma for Prognosis Estimation and Microenvironment Status
por: Chen, Cong, et al.
Publicado: (2022)

Identification and Analysis of the Blood lncRNA Signature for Liver Cirrhosis and Hepatocellular Carcinoma
por: Xia, Qi, et al.
Publicado: (2020)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

Development and Validation of an Immune-Related lncRNA Signature for Predicting the Prognosis of Hepatocellular Carcinoma
por: Kong, Weihao, et al.
Publicado: (2020)

Corrigendum: Identification and Analysis of the Blood lncRNA Signature for Liver Cirrhosis and Hepatocellular Carcinoma
por: Xia, Qi, et al.
Publicado: (2021)

Integrated Analysis of lncRNA-Mediated ceRNA Network Reveals a Prognostic Signature for Hepatocellular Carcinoma
por: Sun, Jian-Rong, et al.
Publicado: (2020)

Identification and validation of ferroptosis-related lncRNA signatures as a novel prognostic model for glioma
por: Huang, Liang, et al.
Publicado: (2022)

Prognostic lncRNA, miRNA, and mRNA Signatures in Papillary Thyroid Carcinoma
por: Wang, Kun, et al.
Publicado: (2020)

Identification of lncRNA biomarkers in hepatocellular carcinoma by comprehensive analysis of the lncRNA-mediated ceRNA network
por: Ye, Dingde, et al.
Publicado: (2022)

Development and validation of a genomic instability-related lncRNA prognostic model for hepatocellular carcinoma
por: Xun, Ziyu, et al.
Publicado: (2023)

Identification and validation of a novel cellular senescence-related lncRNA prognostic signature for predicting immunotherapy response in stomach adenocarcinoma
por: Zeng, Cheng, et al.
Publicado: (2022)

Identification of a Six-lncRNA Signature With Prognostic Value for Breast Cancer Patients
por: Zhao, Erjie, et al.
Publicado: (2020)

Six-lncRNA Immune Prognostic Signature for Cervical Cancer
por: Chen, Qian, et al.
Publicado: (2020)

Development of an Immune-Related LncRNA Prognostic Signature for Glioma
por: Cao, Yudong, et al.
Publicado: (2021)

Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma
por: Cai, Shenglan, et al.
Publicado: (2021)

Discovery and Validation of a Novel Metastasis-Related lncRNA Prognostic Signature for Colorectal Cancer
por: Tang, Qiang, et al.
Publicado: (2022)

Analysis of Pyroptosis-Related Immune Signatures and Identification of Pyroptosis-Related LncRNA Prognostic Signature in Clear Cell Renal Cell Carcinoma
por: Zhong, Ming, et al.
Publicado: (2022)

Identification and Validation of a Novel Immune-Related Four-lncRNA Signature for Lung Adenocarcinoma
por: Wang, Jixin, et al.
Publicado: (2021)

A four-lncRNA risk signature for prognostic prediction of osteosarcoma
por: Liu, Huanlong, et al.
Publicado: (2023)

A novel necroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma
por: Wang, Jianguo, et al.
Publicado: (2022)

Identification of an Autophagy-Related lncRNA Prognostic Signature and Related Tumor Immunity Research in Lung Adenocarcinoma
por: Chen, Hang, et al.
Publicado: (2021)

Identification of a 5-lncRNA-Based Signature for Immune Characteristics and Prognosis of Lung Squamous Cell Carcinoma and Verification of the Function of lncRNA SPATA41
por: Huan, Sheng, et al.
Publicado: (2022)

Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma
por: Liu, Jichang, et al.
Publicado: (2022)

The prognostic value of an autophagy-related lncRNA signature in hepatocellular carcinoma
por: Yang, Shiming, et al.
Publicado: (2021)

Identification of a novel lncRNA prognostic signature and analysis of functional lncRNA AC115619.1 in hepatocellular carcinoma
por: Gan, Binliang, et al.
Publicado: (2023)

Construction of lncRNA prognostic model related to cuproptosis in esophageal carcinoma
por: Zhang, Liming, et al.
Publicado: (2023)

Identification of a Two-lncRNA Signature with Prognostic and Diagnostic Value for Hepatocellular Carcinoma
por: Liu, Huiying, et al.
Publicado: (2022)

Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma
por: Chen, Shanshan, et al.
Publicado: (2022)

Identification and validation of a prognostic model of necroptosis-related lncRNAs in hepatocellular carcinoma
por: Chen, Min, et al.
Publicado: (2022)

Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma
por: Liao, Tianyou, et al.
Publicado: (2022)

Identification of genomic instability related lncRNA signature with prognostic value and its role in cancer immunotherapy in pancreatic cancer
por: Zhu, Xiaole, et al.
Publicado: (2022)

Construction and validation of an angiogenesis-related lncRNA prognostic model in lung adenocarcinoma
por: Gong, Quan, et al.
Publicado: (2023)

Identification and validation of immune‐related lncRNA prognostic signatures for melanoma
por: Xiao, Bo, et al.
Publicado: (2021)

Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma
por: Fu, Yi, et al.
Publicado: (2021)

Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma
por: Bai, Yang, et al.
Publicado: (2021)

Development and validation of a novel endoplasmic reticulum stress-related lncRNA prognostic signature and candidate drugs in breast cancer
por: Cai, Jiehui, et al.
Publicado: (2022)

Prognostic Ferroptosis-Related lncRNA Signatures Associated With Immunotherapy and Chemotherapy Responses in Patients With Stomach Cancer
por: Lai, Donglin, et al.
Publicado: (2022)

The prognostic value and immune landscape of a cuproptosis-related lncRNA signature in head and neck squamous cell carcinoma
por: Li, Yao jun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u85a9cbbk16n4e8jft4mn19mb0